Safety Concerns of Nasal Corticosteroids Usage in Patients With Allergic Rhinitis

Background Intranasal corticosteroids (INCSs) are the first-line treatment for patients with moderate to severe conditions of allergic rhinitis (AR) as per current guidelines. However, patients' knowledge and practice towards the safety of such medications remains ambiguous. Therefore, this stu...

Descripción completa

Detalles Bibliográficos
Autores principales: Almutairi, Talal A, Aldayel, Abdulaziz A, Aldayel, Abdulrahman S, Alotaibi, Fahad, Alhussain, Hamad A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2020
Materias:
Otolaryngology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7686935/
https://www.ncbi.nlm.nih.gov/pubmed/33251078
http://dx.doi.org/10.7759/cureus.11651

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7686935/
https://www.ncbi.nlm.nih.gov/pubmed/33251078
http://dx.doi.org/10.7759/cureus.11651

Ejemplares similares